Skip to main
VRX

VRX Market Capitalization Overview

Market Cap: $2.68B as of Jan 2, 2026

$2.68B
$59.29M (2.27%)past month
As of Jan 2, 2026, VRX has a market capitalization of $2.68B. Over the past 30 days, its market cap has increased by 2.27%, while in the last 12 months, it has increased by 3.74%.

Market capitalization represents the total value of Valeant Pharma International as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

VRX Market Cap Formula = Stock Price * Shares Outstanding

The market cap of VRX helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

VRX Market Cap History

DateMarket CapChange
Dec 1, 2025$2.62B+3.52%
Nov 3, 2025$2.53B+518.79%
Oct 1, 2025$407.77M-13.80%
Sep 2, 2025$473.05M+34.59%
Aug 1, 2025$351.48M-15.91%
Jul 1, 2025$417.96M+51.56%
Jun 2, 2025$275.77M-15.46%
May 1, 2025$326.21M-14.84%
Apr 1, 2025$383.04M-12.83%
Mar 3, 2025$439.42M-1.48%
Feb 3, 2025$445.99M-8.31%
Jan 2, 2025$486.43M+1.53%

VRX End of Year Market Cap History

DateMarket CapChange
2026$2.68B+3.74%
2025$2.58B+421.50%
2024$493.79M+1.22%
2023$487.85M+28.88%
2022$378.53M-77.09%
2021$1.66B

FAQs About Valeant Pharma International (VRX) Market Cap

As of Jan 2, 2026, the market capitalization of VRX is $2.68B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Valeant Pharma International’s market capitalization has increased by 2.27%, changing from $2.62B to $2.68B as of Jan 2, 2026.

In the last 3 months, Valeant Pharma International’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Valeant Pharma International’s market capitalization increased from $493.79M in January to $2.58B in December, reflecting a 421.5% change.

In the past five years, VRX has had a compound annual growth rate (CAGR) of 9.28% in market capitalization. This means its market cap has grown at an average rate of 9.28% per year.

Valeant Pharma International (VRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.